Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

A woman is taking on her father's charity cycle ride from Land’s End to John O’Groats after he died suddenly half way through ...

Vitamin D is linked to a 34% reduction in the relative risk for disease activity in patients with clinically isolated ...

Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Pathways to Cures Roadmap was created by a number of MS representatives and was endorsed by more than 30 organizations.

Highly effective MS treatments like monoclonal antibodies and immune-suppressing drugs “may lead to better clinical outcomes ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

Tolebrutinib delayed the onset of disability progression by 31% for patients with a type of the disease called non-relapsing ...

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that ...